Nirmesh Patel net worth
Quick answer
Nirmesh Patel's estimated net worth is $19K (range $13K – $28K) as of 2026. Nirmesh Patel is Chief Scientific Officer at Cambridge Cancer Genomics. Cambridge Cancer Genomics valuation.
Nirmesh Patel is Chief Scientific Officer at Cambridge Cancer Genomics (YC S17). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Inactive
- Background: Indian, Asian
- Education: PhD in Oncology and Biomedical Sciences from the University of Cambridge
- Region: United Kingdom
- Industries: Healthcare, Diagnostics
- Team size: 25
- Website: http://ccg.ai
Who is Nirmesh Patel?
Nirmesh Patel is associated with Cambridge Cancer Genomics, a company focused on transforming cancer diagnostics through data-driven approaches.
Highlights:
- University of Cambridge
- Deloitte
- Cambridge Cancer Genomics
Background
Heritage labels inferred from name patterns only — not verified. Heritage/background labels may be inferred and are not verified identity documents.
About Cambridge Cancer Genomics
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions...
FAQ: Nirmesh Patel net worth and Cambridge Cancer Genomics valuation
What is Nirmesh Patel's net worth?
Nirmesh Patel's estimated net worth is $19K (range $13K – $28K) as of 2026. Nirmesh Patel is Chief Scientific Officer at Cambridge Cancer Genomics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Cambridge Cancer Genomics valuation?
Cambridge Cancer Genomics's estimated valuation on Entrepreneurial Check is $1.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Nirmesh Patel's role?
Nirmesh Patel is Chief Scientific Officer at Cambridge Cancer Genomics, a Y Combinator-backed startup (batch S17).